Intensive blood pressure control after endovascular thrombectomy for acute ischaemic stroke (ENCHANTED2/MT): a multicentre, open-label, blinded-endpoint, randomised controlled trial (vol 400, pg 1585, 2022)

被引：0
|
作者：
Yang, P.
Song, L.
Zhang, Y.
机构：
来源：
LANCET | 2022年 / 400卷 / 10367期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1926 / 1926
页数：1
相关论文
共 38 条
  • [21] SAFETY AND EFFICACY OF RETEPLASE VERSUS ALTEPLASE FOR ACUTE ISCHEMIC STROKE: A PHASE 2, RANDOMIZED, OPEN-LABEL, BLINDED-ENDPOINT CONTROLLED TRIAL
    Li, S.
    Wang, X.
    Jin, A.
    Wang, Y.
    Zhao, X.
    Li, Z.
    Liu, L.
    Meng, X.
    Wang, Y.
    INTERNATIONAL JOURNAL OF STROKE, 2023, 18 (03) : 428 - 428
  • [22] Endovascular treatment versus no endovascular treatment after 6-24 h in patients with ischaemic stroke and collateral flow on CT angiography (MR CLEAN-LATE) in the Netherlands: a multicentre, open-label, blinded-endpoint, randomised, controlled, phase 3 trial
    Olthuis, Susanne G. H.
    Pirson, F. Anne, V
    Pinckaers, Florentina M. E.
    Hinsenveld, Wouter H.
    Nieboer, Daan
    Ceulemans, Angelique
    Knapen, Robrecht R. M. M.
    Robbe, M. M. Quirien
    Berkhemer, Olvert A.
    van Walderveen, Marianne A. A.
    Nijeholt, Geert J. Lycklama a
    Uyttenboogaart, Maarten
    Schonewille, Wouter J.
    van der Sluijs, P. Matthijs
    Wolff, Lennard
    van Voorst, Henk
    Postma, Alida A.
    Roosendaal, Stefan
    van der Hoorn, Anouk
    Emmer, Bart J.
    Krietemeijer, Menno G. M.
    van Doormaal, Pieter-Jan
    Roozenbeek, Bob
    Goldhoorn, Robert-Jan B.
    Staals, Julie
    Ridder, Inger R. de
    van der Leij, Christiaan
    Coutinho, Jonathan M.
    van der Worp, H. Bart
    Lo, Rob T. H.
    Bokkers, Reinoud P. H.
    Dijk, Ewoud Ivan
    Boogaarts, Hieronymus
    Wermer, Marieke J. H.
    van Es, Adriaan C. G. M.
    van Tuijl, Julia H.
    Kortman, Hans G. J.
    Gons, Rob A. R.
    Yo, Lonneke S. F.
    Vos, Jan-Albert
    Laat, Karlijn F. de
    van Dijk, Lukas C.
    van den Wijngaard, Ido R.
    Hofmeijer, Jeannette
    Martens, Jasper M.
    Brouwers, Paul J. A. M.
    Bulut, Tomas
    Remmers, Michel J. M.
    de Jong, Thijs E. A. M.
    den Hertog, Heleen M.
    LANCET, 2023, 401 (10385): : 1371 - 1380
  • [23] Opinions over Targets for Blood Pressure Control after Mechanical Thrombectomy in Patients with Acute Ischemic Stroke: Baseline Survey for the ENCHANTED2/MT Trial in China
    Li, Yunke
    Zhao, Yang
    Zhang, Xiaoxi
    Sun, Lingli
    Wan, Yingfeng
    Zhang, Yongwei
    Yang, Pengfei
    Song, Lili
    Liu, Jianmin
    Anderson, Craig S.
    CEREBROVASCULAR DISEASES, 2024,
  • [24] Efficacy and safety of glibenclamide therapy after intracerebral haemorrhage (GATE-ICH): A multicentre, prospective, randomised, controlled, open-label, blinded-endpoint, phase 2 clinical trial
    Zhao, Jingjing
    Song, Changgeng
    Li, Deshuai
    Yang, Xiai
    Yu, Liping
    Wang, Kangjun
    Wu, Jun
    Wang, Xiaofeng
    Li, Dongsong
    Zhang, Bo
    Li, Binyong
    Guo, Jun
    Feng, Weikui
    Fu, Feng
    Gu, Xinrong
    Qian, Jian
    Li, Jialong
    Yuan, Xiangjun
    Liu, Qiuwu
    Chen, Jiang
    Wang, Xiaocheng
    Liu, Yi
    Wei, Dong
    Wang, Ling
    Shang, Lei
    Yang, Fang
    Jiang, Wen
    ECLINICALMEDICINE, 2022, 53
  • [25] SAFETY AND EFFICACY OF HUMAN URINARY KALLIDINOGENASE (HUK) FOR LARGE ARTERY ATHEROSCLEROSIS ACUTE ISCHEMIC STROKE(TKLAA): PROTOCOL FOR A MULTICENTRE, PROSPECTIVE, RANDOMISED, OPEN-LABEL, BLINDED-ENDPOINT TRIAL
    Guo, Z. -N.
    Si, X-K.
    Zhang, P.
    Qu, Y.
    Abuduxukuer, R.
    Qi, S.
    Sun, X.
    Yang, Y.
    INTERNATIONAL JOURNAL OF STROKE, 2024, 19 (02) : 121 - 121
  • [26] RECOMBINANT PROUROKINASE IN ACUTE ISCHEMIC STROKE WITHIN 4.5 HOURS OF STROKE ONSET TRIAL-2 (PROST-2): A PHASE 3, MULTI-CENTRE, OPEN-LABEL, BLINDED-ENDPOINT, RANDOMISED CONTROLLED, NON-INFERIORITY TRIAL
    Li, S.
    Gu, H.
    Feng, B.
    Wang, Y.
    INTERNATIONAL JOURNAL OF STROKE, 2024, 19 (02) : 57 - 58
  • [27] Tenecteplase versus alteplase for the management of acute ischaemic stroke in Norway (NOR-TEST 2, part A): a phase 3, randomised, open-label, blinded endpoint, non-inferiority trial
    Kvistad, Christopher Elnan
    Naess, Halvor
    Helleberg, Bernt H.
    Idicula, Titto
    Hagberg, Guri
    Nordby, Linn Marie
    Jenssen, Kristian N.
    Tobro, Hakon
    Rorholt, Dag M.
    Kaur, Kamaljit
    Eltoft, Agnethe
    Evensen, Kristin
    Haasz, Judit
    Singaravel, Guruparan
    Fromm, Annette
    Thomassen, Lars
    LANCET NEUROLOGY, 2022, 21 (06): : 511 - 519
  • [28] Tenecteplase versus alteplase in acute ischaemic cerebrovascular events (TRACE-2): a phase 3, multicentre, open-label, randomised controlled, non-inferiority trial (vol 604, pg 645, 2023)
    Wang, Y.
    Li, S.
    Pan, Y.
    LANCET, 2020, 401 (10382): : 1078 - 1078
  • [29] Tenecteplase versus alteplase in acute ischaemic cerebrovascular events (TRACE-2): a phase 3, multicentre, open-label, randomised controlled, non-inferiority trial (vol 401, pg 645, 2023)
    Wang, Y.
    Li, S.
    Pan, Y.
    LANCET, 2023, 401 (10382): : 1078 - 1078
  • [30] RhPro-UK in acute ischemic stroke within 4.5 h of stroke onset trial-2 (the PROST-2 study): Rationale and design of a multicenter, prospective, randomized, open-label, blinded-endpoint, controlled phase 3 non-inferiority trial
    Li, Shuya
    Gu, Hong-Qiu
    Feng, Baoyu
    Dong, Qiang
    Fan, Dongsheng
    Xu, Yun
    Zhu, Suiqiang
    Wang, Yongjun
    INTERNATIONAL JOURNAL OF STROKE, 2024, 19 (10) : 1182 - 1187
1234